Latest Conference Articles

PSA: To Screen or Not to Screen

Screening for prostate cancer does work, despite controversy about its efficacy, according to IPCC Co-chair Leonard G. Gomella

Integrating New Hormonal Therapies in Advanced Disease

Hormonal therapies have long been the standard of care for metastatic advanced prostate cancer

Novel vaccine approaches: Prospects for PROSTVAC®-VF are bright

As research into novel vaccine approaches for treating advanced prostate cancer continues...

The Overtreatment of Prostate Cancer

Increased prostate cancer screening has led to overtreatment and has not significantly reduced mortality rates in prostate cancer

Dr. Crawford on Moving Prostate Cancer Field Forward

Dr. Gomella Discusses Interdisiplinary Treatment

Breast Reconstruction Trainee Assessment

In this podcast, Maisam Fazel, FRCS, MS, MB BChir, discusses his research into a checklist for breast cancer surgeons.

Dr. Osman on Designing the Program for the MBCC

Dr. Daniel Osman, director of the Miami Breast Cancer Conference, on Designing the Program for the MBCC

Dr. Fazel on Trends in Surgical Training

Maisam Fazel, FRCS, MS, MB BChir, of Imperial College Healthcare NHS Trust in the United Kingdom on Trends in Surgical Training

Need for Survivorship Plans Emphasized

As the number of breast cancer survivors grows, so does the emphasis on establishing individualized survivorship plans

Preoperative Therapy Offers Value to Patients

Preoperative neoadjuvant systemic therapy can be valuable for patients even if they do not achieve a pathologic complete response

Framework for Evaluating Trial Results Detailed

With thousands of clinical trials in play, many oncology specialists are reluctant to embrace findings from newly-released studies

Genomic Profiles as Routine Care Are a Hot Topic

Should genomic profiles be used routinely to determine which breast cancer patients receive adjuvant chemotherapy

Personalized Treatment With Adjuvant Chemotherapy Shows Marginal Progress

Personalized treatment in oncology is a popular concept these days, but the goal remains elusive

A Call for Change in Treating DCIS

It is time to rethink the way oncologists in the United States are treating ductal carcinoma in situ

Phase II Sorafenib Study Yields Positive Results

The addition of sorafenib to capecitabine as a first-line therapy for patients with advanced breast cancer

Dr. Osman on Detecting Malignant Breast Cancer

Daniel A. Osman, MD, Founder and Course Director of the Miami Breast Cancer Conference Discusses Methods for Detecting Malignant Conditions in Breast Cancer

Malpractice Claims Target Breast Cancer Specialists

The climate for medical malpractice litigation in breast cancer treatment seems to be worsening

Diet and Lifestyle Are Factors in Breast Pain

Breast pain is among the most common reasons that women seek medical attention from a breast specialist.

Dr. Osman on Breast Cancer Changes in the Past 10 Years